Discovery of Potent and Selective CDK9 Degraders for Targeting Transcription Regulation in Triple-Negative Breast Cancer
Dan Wei,Hanlin Wang,Qinghe Zeng,Wenjing Wang,Bingbing Hao,Xule Feng,Peipei Wang,Ning Song,Weijuan Kan,Guifang Huang,Xiaoyu Zhou,Minjia Tan,Yubo Zhou,Ruimin Huang,Jia Li,Xiao-Hua Chen
DOI: https://doi.org/10.1021/acs.jmedchem.1c01350
IF: 8.039
2021-09-20
Journal of Medicinal Chemistry
Abstract:Triple-negative breast cancer (TNBC) is highly aggressive with very limited treatment options due to the lack of efficient targeted therapies and thus still remains clinically challenging. Targeting transcription-associated cyclin-dependent kinases to remodel transcriptional regulation shows great promise in cancer therapy. Herein, we report the synthesis, optimization, and evaluation of new series of heterobifunctional molecules as highly selective and efficacious CDK9 degraders, enabling potent inhibition of TNBC cell growth and rapidly targeted degradation of CDK9. Moreover, the most potent CDK9 degrader (compound 45) induces cell apoptosis in vitro and inhibits tumor growth in the MDA-MB-231 TNBC model. Furthermore, the RNA-seq, immunohistochemistry assays demonstrate that the CDK9 degrader downregulates the downstream targets, such as MYC, at the transcriptional level, resulting apoptosis in TNBC cells. Our work establishes that 45 is a highly potent and efficacious CDK9 degrader for targeting transcription regulation, which represents an effective strategy and great potential as a new targeted therapy for TNBC.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c01350.Ligand binding with CDK9, western blotting of CDK proteins, and GSPT1 protein degradation from compounds 28 and 45, experimental procedures for biochemical assays, characterization of intermediate compounds, 1H NMR spectra of targeted compounds, and HPLC purity spectra for all final target compounds (PDF)Molecular formula string for all the final target compounds (CSV)This article has not yet been cited by other publications.
chemistry, medicinal